Pharmabiz7h
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting
SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting ...
Pharmabiz10h
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma
Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...
Pharmabiz12h
AskBio receives US FDA rare paediatric disease & orphan-drug designations for AB-1003 to treat limb-girdle muscular dystrophy type 2I/R9
Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...
Pharmabiz8h
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations
Dizal seeks US FDA approval for sunvozertinib to treat relapsed or refractory NSCLC with EGFR Exon 20 insertion mutations: Shanghai, China Saturday, November 9, 2024, 17:00 Hrs [I ...
Pharmabiz9h
Serres Group receives €1.8 million research grant from Business Finland
Serres Group receives €1.8 million research grant from Business Finland: Espoo, Finland Saturday, November 9, 2024, 16:00 Hrs [IST] Serres has been granted a substantial researc ...
Pharmabiz11h
Transgene & NEC to present new data confirming clinical proof of principle for neoantigen cancer vaccine, TG4050, in head & neck cancer at SITC 2024
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month ...
Pharmabiz13h
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally
MGI Tech partners with Human Cell Atlas to advance human cell mapping efforts globally: Shenzhen, China Saturday, November 9, 2024, 12:00 Hrs [IST] MGI Tech Co., Ltd, a company co ...
Pharmabiz16h
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System
US FDA grants 510(k) clearance to Bayer’s MEDRAD Centargo CT Injection System: Berlin Saturday, November 9, 2024, 09:00 Hrs [IST] Bayer, a global enterprise with core competenci ...
Pharmabiz11h
KPPA to organize webinar series from November 17 to 23 as part of NPW celebration
As part of the National Pharmacy Week (NPW) celebration, the Kerala Private Pharmacist Association (KPPA) is organizing a high-impact webinar series from November 17th to 23rd, connected by the common ...
Pharmabiz17h
National online certificate course for pathologists on cervical cancer screening to begin from November 25
National online certificate course for pathologists on cervical cancer screening to begin from November 25: Shardul Nautiyal, Mumbai Saturday, November 9, 2024, 08:00 Hrs [IST] Th ...
Pharmabiz17h
ICMR announces call for CAR proposals under extramural research programme
ICMR announces call for CAR proposals under extramural research programme: Shardul Nautiyal, Mumbai Saturday, November 9, 2024, 08:00 Hrs [IST] The Indian Council of Medical Resea ...
Pharmabiz11h
SEC recommends approval for MSN Laboratories' sleep disorder drug
The Subject Expert Committee (SEC), which advises the national drug regulator on matters related to approval of new drugs and medical devices and clinical trials, has recommended grant of market ...